Related content

Substratification of stage T1C prostate cancer based on the probability of biochemical recurrence

By Gretzer M.B.   Epstein J.I.   Pound C.R.   Walsh P.C.   Partin A.W.  

Urology, Vol. 60, Iss. 6, 2002-12 ,pp. : 1034-1039

Elsevier

Access to resources Recommend Favorite

Gleason score 7 prostate cancer: a heterogeneous entity? correlation with pathologic parameters and disease-free survival

By Sakr W.A.   Tefilli M.V.   Grignon D.J.   Banerjee M.   Dey J.   Gheiler E.L.   Tiguert R.   Powell I.J.   Wood D.P.  

Urology, Vol. 56, Iss. 5, 2000-11 ,pp. : 730-734

Elsevier

Access to resources Recommend Favorite

Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: progress pathology report of the Italian PROSIT study

By Bono A.V.   Pagano F.   Montironi R.   Zattoni F.   Manganelli A.   Selvaggi F.P.   Comeri G.   Fiaccavento G.   Guazzieri S.   Selli C.   Lembo A.   Cosciani-Cunico S.   Potenzoni D.   Muto G.   Diamanti L.   Santinelli A.   Mazzucchelli R.   Prayer-Galletti T.   on behalf of the Italian PROSIT Study Group  

Urology, Vol. 57, Iss. 1, 2001-01 ,pp. : 117-121

Elsevier

Access to resources Recommend Favorite

Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy

By Merrick G.S.   Butler W.M.   Galbreath R.W.   Lief J.H.   Adamovich E.  

Urology, Vol. 60, Iss. 1, 2002-07 ,pp. : 98-103

Elsevier

Access to resources Recommend Favorite

Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer

By D'Amico A.V.   Whittington R.   Malkowicz S.B.   Wu Y.H.   Chen M.-H.   Art M.   Tomaszewski J.E.   Wein A.  

Urology, Vol. 55, Iss. 4, 2000-04 ,pp. : 572-577

Elsevier

Access to resources Recommend Favorite